Truog WE - Search Results

1

Neonatal nitric oxide use: predictors of response and financial implications.

Truog WE, Castor CA, Sheffield MJ. Truog WE, et al. J Perinatol. 2003 Mar;23(2):128-32. doi: 10.1038/sj.jp.7210864. J Perinatol. 2003. PMID: 12673262

2

Crossover trial comparing pressure support with synchronized intermittent mandatory ventilation.

Olsen SL, Thibeault DW, Truog WE. Olsen SL, et al. Among authors: truog we. J Perinatol. 2002 Sep;22(6):461-6. doi: 10.1038/sj.jp.7210772. J Perinatol. 2002. PMID: 12168123 Clinical Trial.

3

Interaction of endogenous endothelin-1 and inhaled nitric oxide in term and preterm infants.

Truog WE, Pallotto E, Clark P, Banks B, Kaftan HA, Ekekezie II, Norberg M, Ballard RA. Truog WE, et al. Clin Sci (Lond). 2002 Aug;103 Suppl 48:294S-297S. doi: 10.1042/CS103S294S. Clin Sci (Lond). 2002. PMID: 12193107

4

Endogenous production of nitric oxide in endotoxemic piglets.

Kaftan HA, Clark PL, Norberg M, Garg U, Thibeault DW, Truog WE. Kaftan HA, et al. Among authors: truog we. Biol Neonate. 2003;83(1):42-8. doi: 10.1159/000067008. Biol Neonate. 2003. PMID: 12566683

5

Exhaled nitric oxide and tracheal endothelin-1 in preterm infants with and without RDS.

Olsen SL, Clark PL, Thibeault DW, Norberg M, Truog WE. Olsen SL, et al. Among authors: truog we. Pediatr Pulmonol. 2003 Nov;36(5):421-6. doi: 10.1002/ppul.10371. Pediatr Pulmonol. 2003. PMID: 14520725 Clinical Trial.

6

Pulmonary nitric oxide synthases and nitrotyrosine: findings during lung development and in chronic lung disease of prematurity.

Sheffield M, Mabry S, Thibeault DW, Truog WE. Sheffield M, et al. Among authors: truog we. Pediatrics. 2006 Sep;118(3):1056-64. doi: 10.1542/peds.2006-0195. Pediatrics. 2006. PMID: 16950998

7

Inflammatory markers and mediators in tracheal fluid of premature infants treated with inhaled nitric oxide.

Truog WE, Ballard PL, Norberg M, Golombek S, Savani RC, Merrill JD, Parton LA, Cnaan A, Luan X, Ballard RA; Nitric Oxide (to Prevent) Chronic Lung Disease Study Investigators. Truog WE, et al. Pediatrics. 2007 Apr;119(4):670-8. doi: 10.1542/peds.2006-2683. Pediatrics. 2007. PMID: 17403837 Clinical Trial.

8

Inhaled nitric oxide for the prevention of bronchopulmonary dysplasia.

Truog WE. Truog WE. Expert Opin Pharmacother. 2007 Jul;8(10):1505-13. doi: 10.1517/14656566.8.10.1505. Expert Opin Pharmacother. 2007. PMID: 17661732 Review.

9

Two-year neurodevelopmental outcomes of ventilated preterm infants treated with inhaled nitric oxide.

Walsh MC, Hibbs AM, Martin CR, Cnaan A, Keller RL, Vittinghoff E, Martin RJ, Truog WE, Ballard PL, Zadell A, Wadlinger SR, Coburn CE, Ballard RA; NO CLD Study Group. Walsh MC, et al. Among authors: truog we. J Pediatr. 2010 Apr;156(4):556-61.e1. doi: 10.1016/j.jpeds.2009.10.011. Epub 2010 Feb 6. J Pediatr. 2010. PMID: 20138299 Free PMC article. Clinical Trial.

10

Predicting death or tracheostomy placement in infants with severe bronchopulmonary dysplasia.

Murthy K, Savani RC, Lagatta JM, Zaniletti I, Wadhawan R, Truog W, Grover TR, Zhang H, Asselin JM, Durand DJ, Short BL, Pallotto EK, Padula MA, Dykes FD, Reber KM, Evans JR. Murthy K, et al. J Perinatol. 2014 Jul;34(7):543-8. doi: 10.1038/jp.2014.35. Epub 2014 Mar 20. J Perinatol. 2014. PMID: 24651732

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

204 results

Search Page

Filters